Following the pandemic, how to continue to lead the profession globally and support our members during those uncertain times became a core priority for FIP in 2023. As we move on from responding directly to COVID-19 to responding to the aftermath and to readying ourselves for future pandemics and health emergencies, FIP sought to derive key lessons, recommendations and considerations for the future in another report, “Pandemic Preparedness, Response and Recovery: Lessons Learnt for Global Pharmacy” which will be launched at the digital event on August 16.

The event moderators are:
- Sherly Meilianti – FIP Data and Intelligence Specialist
- Farah Aqqad – FIP Regional, Enngagement Support and Development Manager
- Nour Eltahla – FIP Projects coordinator for equity, sustainability policy and development, The Netherlands

The event speakers are:
- Lina Bader – FIP Lead for equity, sustainability policy and development, The Netherlands
- Rao Vadlamudi - Immediate Past President, Indian Pharmaceutical Association (IPA); Professional Secretary, SEARPharm Forum, India
- Jackie Maimin, Chief Executive Officer, Independent Community Pharmacy Association (ICPA); Council member, Pharmaceutical Society of South Africa, South Africa
- Rony Zeenny, Director, Department of Pharmacy, American University of Beirut Medical Centre; INSPECT-LB, Lebanon
- Clare Fitzell, Head of Strategic Policy, Irish Pharmacy Union, Ireland
- Leonor Soares, International Affairs, Portuguese Pharmaceutical Society, Portugal
- Nobuo Yamamoto, President, Japan Pharmaceutical Association, Japan
- Maria Mendes, Area Manager, Public Health Interventions and Pharmacy Services, National Association of Pharmacies, Portugal
- Sofía Segura, University of Costa Rica and College of Pharmacists of Costa Rica, Costa Rica
- Mary Ann Sant Fournier, President, Malta Chamber of Pharmacists, Malta

FIP is committed to supporting countries to develop policies that enable pharmacies and pharmacists to deliver integrated vaccination services throughout the life-course and as part of wider national immunisation policies. This event is delivered as part of a new FIP programme supported by Pfizer, which aims to provide our members with approaches and tools for tackling key policy enablers that determine equity, access and sustainability of pharmacy-based life-course immunisation.

The success of pharmacy-based vaccination depends on various policy factors, one of which is access to data and vaccination records. FIP data shows that pharmacists’ access to patient vaccination records vary widely across countries and regions. Understanding the different models and country experiences is key to wider implementation. This event will feature pharmacy leadership bodies from across the world explaining their progress with access to records and how this impacts access to vaccination through pharmacies.

Moderator:
- Lina Bader, FIP Lead for Equity, sustainability policy and development International Pharmaceutical Federation (FIP) - Netherlands

Facilitator:
- Nour Eltahla, FIP Projects coordinator for Equity, sustainability policy and development FIP - Netherlands

Panellists:
- Fei Sim, National President Pharmaceutical Society of Australia - Australia
- Daphné Holt, Chair Coalition for Life-course Immunisation - France
- Sarah Sorum, Executive Vice President & CEO Pharmacy Society of Wisconsin, an ASHP state-affiliate - United States
- Catherine Duggan, FIP CEO FIP - The Netherlands

FIP is committed to supporting countries to develop policies that enable pharmacies and pharmacists to deliver integrated vaccination services throughout the life-course and as part of wider national immunisation policies. This event is delivered as part of a new FIP programme supported by Pfizer, which aims to provide our members with approaches and tools for tackling key policy enablers that determine equity, access and sustainability of pharmacy-based life-course immunisation.

The success of pharmacy-based vaccination depends on various policy factors, one of which is access to data and vaccination records. FIP data shows that pharmacists’ access to patient vaccination records vary widely across countries and regions. Understanding the different models and country experiences is key to wider implementation. This event will feature pharmacy leadership bodies from across the world explaining their progress with access to records and how this impacts access to vaccination through pharmacies.

Moderator:
- Sherif Guorgui, FIP President, Community Pharmacy Section, So-CEO OnPharm-United, Canada

Panellists:
- Sarah Sorum, Executive Vice President & CEO, Pharmacy Society of Wisconsin, an ASHP state-affiliate, United States
- Marisol Flores Campos, Pharmacovigilance Officer, Punto Seguro, Costa Rica
- Pedro Costa e Silva, Manager - Health Services Business Unit, Associação Nacional das Farmácias (ANF), Portugal
- Omaima Arab, Scientific evaluation expert, Saudi Food and Drug Authority, Saudi Arabia

FIP is committed to supporting countries to develop policies that enable pharmacies and pharmacists to deliver integrated vaccination services throughout the life-course and as part of wider national immunisation policies. This event is delivered as part of a new FIP programme supported by Pfizer, which aims to provide our members with approaches and tools for tackling key policy enablers that determine equity, access and sustainability of pharmacy-based life-course immunisation.

Regulations of pharmacy practice is a critical determinant of pharmacists’ authority to administer and/or prescribe vaccines. FIP data shows that regulations on pharmacy-based vaccination vary widely across countries and regions. Understanding the different models and country experiences is key to wider implementation. This event will feature a number of pharmacy leadership bodies describing how pharmacy-based vaccination, including prescribing, is regulated in their countries.

Moderator:
- Jaime Acosta, FIP-CPS Professional Secretary Community, Pharmacist Farmacia Acosta, Spain

Panellists:
- Hanne Andresen, Director Pharmaceutical Affairs Norwegian Pharmacy Association, Norway
- Fei Sim, National President Pharmaceutical Society of Australia, Australia
- Luna Bizri, Founder and manager of community pharmacy; Clinical Assistant professor; Adjunct faculty member Lunapharm pharmacy; Lebanese International University; Lebanese American University, Lebanon
- Joyce Mariama Kallon, Team Lead for the supply Chain and logistics vaccine unit Immunisation unit, Sierra Leone

Remuneration of pharmacy vaccinations is one of the key policy enablers of pharmacy-based vaccinations, and thus life-course immunisation. FIP data shows that remuneration models vary widely across countries and regions. Understanding the different models and country experiences is key to wider implementation. This event will feature a number of pharmacy leadership bodies sharing their remuneration models and journeys for the benefit of policy-enablement everywhere.

This event is delivered as part of a new FIP programme supported by Pfizer, which aims to provide our members with approaches and tools for tackling key policy enablers that determine equity, access and sustainability of pharmacy-based life-course immunisation.

Moderator:
- Sari Westermarck, Community pharmacist FIP Community Pharmacy Section, Finland

Panellists:
- Eleftherios Marinos, General Secretary-Federation of Pharmacists’ Cooperatives of Greece, Greece
- Ahmad Al-Rusasi, General manager/Lecturer Alnoor Drug Store, Jordan
- Sham Moodley, Pharmacist Pharmaceutical Society of South Africa/Independent Community Pharmacy Assoc (ICPA), South Africa
- Susan O’Dwyer, Head of Governance and Pharmacy Service, Irish Pharmacy Union, Ireland
- Luís Lourenço, President of the South and Autonomous Regions Branch of the Portuguese Pharmaceutical Society, Portuguese Pharmaceutical Society, Portugal